REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company dedicated to improving lives through the curative potential of gene therapy. Their focus is on developing innovative therapies for diseases with significant unmet needs, primarily in the retinal, metabolic and neurodegenerative therapeutic areas. REGENXBIO's proprietary NAV® Technology Platform utilizes adeno-associated virus (AAV) vectors, modified viruses that serve as delivery vehicles for healthy genes, to address genetic defects or enable the body to produce therapeutic proteins.

REGENXBIO is committed to a patient-centric culture, driven by results, and fostering collaboration. They have a robust pipeline of investigational AAV Therapeutics, including ABBV-RGX-314 for retinal diseases, RGX-202 for Duchenne Muscular Dystrophy, and RGX-121 for MPS II (Hunter Syndrome). They have a state-of-the-art manufacturing facility, enabling commercial-ready production of their AAV vectors, and have established partnerships and licenses with other biotechnology companies to expand the reach and impact of their NAV® Technology Platform.

REGENXBIO does not explicitly mention job flexibility on their website or in the provided job posting.

REGENXBIO offers comprehensive and competitive benefits for employees and their families, including a range of perks. While specific details on the benefits package aren't mentioned, they are highlighted as a draw for potential employees seeking personal and professional growth opportunities.

REGENXBIO is a clinical-stage biotechnology company focused on improving lives through the curative potential of gene therapy. They develop innovative gene therapies for diseases with significant unmet needs, utilizing their proprietary NAV® Technology Platform to deliver genes to cells. Their goal is to provide one-time treatments with long-lasting effects, potentially altering the course of diseases and delivering improved patient outcomes in areas such as retinal, metabolic, and neurodegenerative diseases.

REGENXBIO promotes a culture that is patient-centric, results-driven, and collaborative. They prioritize fostering an environment where employees feel empowered to work together and find innovative solutions, all while remaining focused on improving the lives of patients. The company also recognizes and rewards the perseverance of its employees who are dedicated to advancing their mission.

REGENXBIO is committed to fostering a diverse, equitable, and inclusive workplace. They believe that a culture focused on patients, driven by results, and one that fosters collaboration is essential to their mission of improving lives through gene therapy. This commitment is reflected in their efforts to create a workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. They are dedicated to building a diverse and inclusive workforce by attracting, developing, and retaining talented individuals from a wide range of backgrounds and experiences.